Total Share Capital Notification Admission to trading on Euronext Growth Brussels of newly issued ordinary shares

30th September 2020 - 4:48 pm

ImmuPharma PLC (LSE:IMM), (Euronext Growth Brussels: ALIMM), the specialist drug discovery and development company announces that in accordance with its obligations to the Company’s Euronext listing and following an application of Article 15 of the Belgian Law of 2 May 2007, the total number of shares with voting rights and the total number of voting rights can be downloaded click here

 

Share this article